Wayfinding Financial’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Wayfinding Financial's PFE Position: Q2 2026 in Review
Wayfinding Financial sold out of Pfizer (PFE) in Q2 2026, closing a stake of 7,254 shares — an estimated $203K sold.
Wayfinding Financial first reported a position in PFE in Q4 2021 and held it in 14 quarters. The position peaked at $408K in Q2 2022. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Wayfinding Financial reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
- Wayfinding Financial sold 7,254 Pfizer shares in Q2 2026, an estimated $203K.
- Wayfinding Financial first reported a position in Pfizer in Q4 2021 and held it in 14 quarters.
- Wayfinding Financial's Pfizer position peaked at $408K in Q2 2022.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Wayfinding Financial's 13F filing for Q2 2026, filed 13 Aug 2026.